[HTML][HTML] Progresses towards safe and efficient gene therapy vectors
The emergence of genetic engineering at the beginning of the 1970′ s opened the era of
biomedical technologies, which aims to improve human health using genetic manipulation …
biomedical technologies, which aims to improve human health using genetic manipulation …
Interests of chitosan nanoparticles ionically cross-linked with tripolyphosphate for biomedical applications
L Bugnicourt, C Ladavière - Progress in polymer science, 2016 - Elsevier
The process of ionic gelation is one of the easiest ways to develop chitosan nanoparticles
reported so far in the literature. Its success is mainly due to its one-shot synthesis, and to the …
reported so far in the literature. Its success is mainly due to its one-shot synthesis, and to the …
Thermoresponsive chitosan–agarose hydrogel for skin regeneration
Healing enhancement and pain control are critical issues on wound management. So far,
different wound dressings have been developed. Among them, hydrogels are the most …
different wound dressings have been developed. Among them, hydrogels are the most …
Production and characterization of chitosan/gelatin/β-TCP scaffolds for improved bone tissue regeneration
IR Serra, R Fradique, MCS Vallejo, TR Correia… - Materials Science and …, 2015 - Elsevier
Recently, bone tissue engineering emerged as a viable therapeutic alternative, comprising
bone implants and new personalized scaffolds to be used in bone replacement and …
bone implants and new personalized scaffolds to be used in bone replacement and …
Polysaccharide-based nucleic acid nanoformulations
K Raemdonck, TF Martens, K Braeckmans… - Advanced drug delivery …, 2013 - Elsevier
Therapeutic application of nucleic acids requires their encapsulation in nanosized carriers
that enable safe and efficient intracellular delivery. Before the desired site of action is …
that enable safe and efficient intracellular delivery. Before the desired site of action is …
Chitosan in non-viral gene delivery: Role of structure, characterization methods, and insights in cancer and rare diseases therapies
B Santos-Carballal, E Fernández Fernández… - Polymers, 2018 - mdpi.com
Non-viral gene delivery vectors have lagged far behind viral ones in the current pipeline of
clinical trials of gene therapy nanomedicines. Even when non-viral nanovectors pose less …
clinical trials of gene therapy nanomedicines. Even when non-viral nanovectors pose less …
Optimization of liquid overlay technique to formulate heterogenic 3D co‐cultures models
EC Costa, VM Gaspar, P Coutinho… - Biotechnology and …, 2014 - Wiley Online Library
ABSTRACT Three‐dimensional (3D) cell culture models of solid tumors are currently having
a tremendous impact in the in vitro screening of candidate anti‐tumoral therapies. These 3D …
a tremendous impact in the in vitro screening of candidate anti‐tumoral therapies. These 3D …
Minicircle DNA vectors for gene therapy: advances and applications
V Gaspar, D Melo-Diogo, E Costa… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Nucleic-acid-based biopharmaceuticals enclose a remarkable potential for
treating debilitating or life-threatening diseases that currently remain incurable. This …
treating debilitating or life-threatening diseases that currently remain incurable. This …
Bioreducible poly (2-ethyl-2-oxazoline)–PLA–PEI-SS triblock copolymer micelles for co-delivery of DNA minicircles and Doxorubicin
The co-delivery of minicircle DNA (mcDNA) and small anti-cancer drugs via stimuli-sensitive
nanocarriers is a promising approach for combinatorial cancer therapy. However, the …
nanocarriers is a promising approach for combinatorial cancer therapy. However, the …
Cell-specific transmembrane injection of molecular cargo with gold nanoparticle-generated transient plasmonic nanobubbles
EY Lukianova-Hleb, DS Wagner, MK Brenner… - Biomaterials, 2012 - Elsevier
Optimal cell therapies require efficient, selective and rapid delivery of molecular cargo into
target cells without compromising their viability. Achieving these goals ex vivo in bulk …
target cells without compromising their viability. Achieving these goals ex vivo in bulk …